Biogen to Host Investor Webcasts from Clinical Trials on Alzheimer?s Disease (CTAD) Congress on December 5, 2019

CAMBRIDGE, Mass., Nov. 04, 2019 (GLOBE NEWSWIRE) — Biogen (Nasdaq: BIIB) today announced it will host live webcasts of its oral presentation and a Q&A session related to its Alzheimer?s disease investigational therapy, aducanumab, at the upcoming Clinical Trials on Alzheimer?s Disease (CTAD) annual congress in San Diego, California.??